Search for: "State Of Washington, Respondent V D. A. B, Appellant" Results 121 - 129 of 129
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
9 Nov 2007, 6:16 pm
Banegas CA2/2 IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA SECOND APPELLATE DISTRICT DIVISION TWO THE PEOPLE, Plaintiff and Respondent, v. [read post]
31 Aug 2007, 6:05 am
Personally, I'd rather pay the few extra bucks and keep my skull;And finally:Blawg Review #123 is up at Texas Appellate Law blog;Grand Rounds is up at Rickety Contrivances of Doing Good, for those with medical interests;The Cavalcade of Risk is hosted this week by Health Affairs;Food poisoning legal guru Bill Marler is the focus of a long (and flattering) magazine profile;Trial Ad Notes reports that B-List and C-List celebrities seek new life on Jury Duty, coming to… [read post]
6 Feb 2007, 4:12 am
Maryland Rule 11-106 provides in pertinent part that "[t]he respondent is entitled to be represented in all proceedings under this Title by counsel retained by him, his parent, or appointed pursuant to the provisions of subsection (b) (2) and (3) of this Rule. [read post]